BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36264773)

  • 1. HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell cycle transition through transcriptional repression of p21.
    Lin ZH; He JM; Lai SC; Ding N; Jiang Y; He XK; Liu XS; Huang ZH
    Neoplasma; 2022 Dec; 69(6):1303-1313. PubMed ID: 36264773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression.
    He J; Ge Q; Lin Z; Shen W; Lin R; Wu J; Wang B; Lu Y; Chen L; Liu X; Zheng W; Zhang Y; Wang L; Wang K; Wang L; Zhuo W; Chen S
    FASEB J; 2020 Jun; 34(6):8544-8557. PubMed ID: 32356314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer.
    Kim J; Bae DH; Kim JH; Song KS; Kim YS; Kim SY
    Oncol Rep; 2019 Jul; 42(1):202-212. PubMed ID: 31115563
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Yu J; Zhang X; Ma Y; Li Z; Tao R; Chen W; Xiong S; Han X
    Cancer Biother Radiopharm; 2021 Feb; 36(1):95-105. PubMed ID: 32552008
    [No Abstract]   [Full Text] [Related]  

  • 5. HOXC10 promotes cell migration, invasion, and tumor growth in gastric carcinoma cells through upregulating proinflammatory cytokines.
    Li J; Tong G; Huang C; Luo Y; Wang S; Zhang Y; Cheng B; Zhang Z; Wu X; Liu Q; Li M; Li L; Ni B
    J Cell Physiol; 2020 Apr; 235(4):3579-3591. PubMed ID: 31552684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXC10 promotes gastric cancer cell invasion and migration via regulation of the NF-κB pathway.
    Yao S; He L; Zhang Y; Ye L; Lai Y; Huang L; Wu L; Wu G; Zhu S
    Biochem Biophys Res Commun; 2018 Jun; 501(3):628-635. PubMed ID: 29753747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP.
    Dang Y; Chen J; Feng W; Qiao C; Han W; Nie Y; Wu K; Fan D; Xia L
    Theranostics; 2020; 10(8):3833-3848. PubMed ID: 32206125
    [No Abstract]   [Full Text] [Related]  

  • 8. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
    Zheng J; Ge P; Liu X; Wei J; Wu G; Li X
    Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.
    Miwa T; Kanda M; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
    Ann Surg Oncol; 2019 May; 26(5):1535-1543. PubMed ID: 30673899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome.
    Feng X; Li T; Liu Z; Shi Y; Peng Y
    Mol Biosyst; 2015 Nov; 11(11):2946-54. PubMed ID: 26279264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E2F1-HOXB9/PBX2-CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer.
    Zhang J; Chen B; Wang Y; Liu X; Yan H; Wong KY; Chan AK; Cheung AH; Chow C; Xu D; Wang S; Huang B; Liang L; Ke H; Wong CC; Wu WK; Cheng AS; Yu J; Lo KW; To KF; Kang W
    J Pathol; 2023 Aug; 260(4):402-416. PubMed ID: 37272544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.
    Li S; Zhang W; Wu C; Gao H; Yu J; Wang X; Li B; Jun Z; Zhang W; Zhou P; Shi J; Wang L; Gao Y; Li S; Tao B
    FEBS J; 2018 Jun; 285(12):2278-2291. PubMed ID: 29676849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
    Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
    J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
    Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
    Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer.
    Liu Z; Chen Z; Fan R; Jiang B; Chen X; Chen Q; Nie F; Lu K; Sun M
    Mol Cancer; 2017 Apr; 16(1):82. PubMed ID: 28441948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53.
    Zhang L; Li W; Cao L; Xu J; Qian Y; Chen H; Zhang Y; Kang W; Gou H; Wong CC; Yu J
    Oncogene; 2019 Jun; 38(23):4590-4604. PubMed ID: 30745575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEAD-box helicase 56 functions as an oncogene promote cell proliferation and invasion in gastric cancer via the FOXO1/p21 Cip1/c-Myc signaling pathway.
    Wang J; Wang Y; Wang J; Zhang S; Yu Z; Zheng K; Fu Z; Wang C; Huang W; Chen J
    Bioengineered; 2022 May; 13(5):13970-13985. PubMed ID: 35723050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of HOXC10 gene on biological behaviors of glioma cells and mechanism in tumor microenvironment].
    Jiang WY; Lei QY; Liu SS; Yang L; Yang B; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):228-237. PubMed ID: 35316872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.